179 related articles for article (PubMed ID: 10722652)
1. Smad6 as a transcriptional corepressor.
Bai S; Shi X; Yang X; Cao X
J Biol Chem; 2000 Mar; 275(12):8267-70. PubMed ID: 10722652
[TBL] [Abstract][Full Text] [Related]
2. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling.
Shi X; Yang X; Chen D; Chang Z; Cao X
J Biol Chem; 1999 May; 274(19):13711-7. PubMed ID: 10224145
[TBL] [Abstract][Full Text] [Related]
3. Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.
Lin X; Liang YY; Sun B; Liang M; Shi Y; Brunicardi FC; Shi Y; Feng XH
Mol Cell Biol; 2003 Dec; 23(24):9081-93. PubMed ID: 14645520
[TBL] [Abstract][Full Text] [Related]
4. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.
Hullinger TG; Pan Q; Viswanathan HL; Somerman MJ
Exp Cell Res; 2001 Jan; 262(1):69-74. PubMed ID: 11120606
[TBL] [Abstract][Full Text] [Related]
6. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
Ishida W; Hamamoto T; Kusanagi K; Yagi K; Kawabata M; Takehara K; Sampath TK; Kato M; Miyazono K
J Biol Chem; 2000 Mar; 275(9):6075-9. PubMed ID: 10692396
[TBL] [Abstract][Full Text] [Related]
7. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
Shi X; Bai S; Li L; Cao X
J Biol Chem; 2001 Jan; 276(1):850-5. PubMed ID: 11042172
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression.
Wan M; Shi X; Feng X; Cao X
J Biol Chem; 2001 Mar; 276(13):10119-25. PubMed ID: 11139569
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity.
Nudi M; Ouimette JF; Drouin J
Mol Endocrinol; 2005 May; 19(5):1329-42. PubMed ID: 15695370
[TBL] [Abstract][Full Text] [Related]
10. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
11. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.
Yoshida Y; von Bubnoff A; Ikematsu N; Blitz IL; Tsuzuku JK; Yoshida EH; Umemori H; Miyazono K; Yamamoto T; Cho KW
Mech Dev; 2003 May; 120(5):629-37. PubMed ID: 12782279
[TBL] [Abstract][Full Text] [Related]
12. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling.
Bai S; Cao X
J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531
[TBL] [Abstract][Full Text] [Related]
13. CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.
Ionescu AM; Drissi H; Schwarz EM; Kato M; Puzas JE; McCance DJ; Rosier RN; Zuscik MJ; O'Keefe RJ
J Cell Physiol; 2004 Mar; 198(3):428-40. PubMed ID: 14755548
[TBL] [Abstract][Full Text] [Related]
14. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer.
Brown CO; Chi X; Garcia-Gras E; Shirai M; Feng XH; Schwartz RJ
J Biol Chem; 2004 Mar; 279(11):10659-69. PubMed ID: 14662776
[TBL] [Abstract][Full Text] [Related]
15. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Hex gene expression by a Smads-dependent signaling pathway.
Zhang W; Yatskievych TA; Cao X; Antin PB
J Biol Chem; 2002 Nov; 277(47):45435-41. PubMed ID: 12270938
[TBL] [Abstract][Full Text] [Related]
17. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
18. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
